256,072 Shares in Agilent Technologies, Inc. (NYSE:A) Bought by Raiffeisen Bank International AG

Raiffeisen Bank International AG acquired a new position in shares of Agilent Technologies, Inc. (NYSE:A) during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 256,072 shares of the medical research company’s stock, valued at approximately $34,421,000. Raiffeisen Bank International AG owned 0.09% of Agilent Technologies as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Sienna Gestion boosted its holdings in shares of Agilent Technologies by 29.8% in the fourth quarter. Sienna Gestion now owns 78,445 shares of the medical research company’s stock worth $10,537,000 after buying an additional 17,991 shares during the period. Sequoia Financial Advisors LLC raised its position in Agilent Technologies by 8.5% during the fourth quarter. Sequoia Financial Advisors LLC now owns 33,898 shares of the medical research company’s stock valued at $4,554,000 after acquiring an additional 2,664 shares in the last quarter. S.E.E.D. Planning Group LLC lifted its position in shares of Agilent Technologies by 12.7% in the fourth quarter. S.E.E.D. Planning Group LLC now owns 42,587 shares of the medical research company’s stock worth $5,721,000 after buying an additional 4,805 shares during the last quarter. Prudential PLC grew its stake in Agilent Technologies by 16.0% in the 4th quarter. Prudential PLC now owns 73,273 shares of the medical research company’s stock valued at $9,843,000 after buying an additional 10,128 shares during the last quarter. Finally, Commonwealth Equity Services LLC grew its stake in shares of Agilent Technologies by 9.8% in the fourth quarter. Commonwealth Equity Services LLC now owns 43,862 shares of the medical research company’s stock worth $5,892,000 after acquiring an additional 3,915 shares during the last quarter.

Agilent Technologies Price Performance

Shares of A stock opened at $111.49 on Thursday. The firm has a market cap of $31.79 billion, a price-to-earnings ratio of 25.63, a PEG ratio of 3.25 and a beta of 1.27. Agilent Technologies, Inc. has a 12 month low of $96.43 and a 12 month high of $155.35. The company has a quick ratio of 1.66, a current ratio of 2.20 and a debt-to-equity ratio of 0.56. The stock has a 50-day moving average price of $110.78 and a 200 day moving average price of $128.45.

Agilent Technologies (NYSE:A) last posted its quarterly earnings results on Wednesday, February 26th. The medical research company reported $1.31 earnings per share for the quarter, topping analysts’ consensus estimates of $1.27 by $0.04. Agilent Technologies had a net margin of 19.27% and a return on equity of 25.56%. The business had revenue of $1.68 billion during the quarter, compared to the consensus estimate of $1.67 billion. Research analysts expect that Agilent Technologies, Inc. will post 5.54 EPS for the current year.

Agilent Technologies Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, April 23rd. Investors of record on Tuesday, April 1st were issued a dividend of $0.248 per share. This represents a $0.99 dividend on an annualized basis and a yield of 0.89%. The ex-dividend date of this dividend was Tuesday, April 1st. Agilent Technologies’s dividend payout ratio is currently 22.76%.

Wall Street Analyst Weigh In

A has been the topic of a number of analyst reports. TD Cowen upped their target price on shares of Agilent Technologies to $135.00 and gave the company a “buy” rating in a research note on Thursday, April 10th. Robert W. Baird cut their price target on shares of Agilent Technologies from $161.00 to $159.00 and set an “outperform” rating for the company in a report on Thursday, February 27th. Barclays reduced their price target on shares of Agilent Technologies from $138.00 to $115.00 and set an “equal weight” rating on the stock in a research report on Thursday, April 10th. Wells Fargo & Company dropped their price objective on shares of Agilent Technologies from $155.00 to $135.00 and set an “overweight” rating for the company in a report on Thursday, April 17th. Finally, Jefferies Financial Group decreased their price target on Agilent Technologies from $135.00 to $116.00 and set a “hold” rating on the stock in a research report on Monday, April 21st. Seven investment analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. According to data from MarketBeat.com, Agilent Technologies currently has an average rating of “Moderate Buy” and a consensus price target of $143.00.

Insider Buying and Selling at Agilent Technologies

In other Agilent Technologies news, Director Daniel K. Podolsky sold 1,819 shares of the business’s stock in a transaction that occurred on Monday, March 31st. The stock was sold at an average price of $116.46, for a total value of $211,840.74. Following the sale, the director now owns 35,737 shares in the company, valued at approximately $4,161,931.02. The trade was a 4.84% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, VP Rodney Gonsalves sold 1,908 shares of the business’s stock in a transaction on Monday, March 17th. The stock was sold at an average price of $121.98, for a total transaction of $232,737.84. Following the completion of the sale, the vice president now directly owns 21,786 shares in the company, valued at approximately $2,657,456.28. This represents a 8.05% decrease in their position. The disclosure for this sale can be found here.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.